Abstract

Introduction: Sex differences in inflammation are obvious and contribute to divergences in the incidence and severity of inflammation-related diseases that frequently preponderate in women. Lipid mediators (LMs), mainly produced by lipoxygenase (LOX) and cyclooxygenase (COX) pathways from polyunsaturated fatty acids (PUFAs), regulate all stages of inflammation. Experimental and clinical studies revealed sex divergences for selected LM pathways without covering the entire LM spectrum, and only few studies have addressed the respective role of sex hormones. Here, we performed the comprehensive LM profile analysis with inflammatory peritoneal exudates and plasma from male and female mice in zymosan-induced peritonitis to identify the potential sex differences in LM biosynthesis during the inflammatory response. We also addressed the impact of sex hormones by employing gonadectomy. Methods: Adult male and female CD1 mice received intraperitoneal injection of zymosan to induce peritonitis, a well-established experimental model of acute, self-resolving inflammation. Mice were gonadectomized 5 weeks prior to peritonitis induction. Peritoneal exudates and plasma were taken at 4 (peak of inflammation) and 24 h (onset of resolution) post zymosan and subjected to UPLC–MS-MS–based LM signature profiling; exudates were analyzed for LM biosynthetic proteins by Western blot; and plasma was analyzed for cytokines by ELISA. Results: Pro-inflammatory COX and 5-LOX products predominated in the peritoneum of males at 4 and 24 h post-zymosan, respectively, with slightly higher 12/15-LOX products in males after 24 h. Amounts of COX-2, 5-LOX/FLAP, and 15-LOX-1 were similar in exudates of males and females. In plasma of males, only moderate elevation of these LMs was apparent. At 4 h post-zymosan, gonadectomy strongly elevated 12/15-LOX products in the exudates of males, while in females, free PUFA and LOX products were rather impaired. In plasma, gonadectomy impaired most LMs in both sexes at 4 h with rather up-regulatory effects at 24 h. Finally, elevated 15-LOX-1 protein was evident in exudates of males at 24 h which was impaired by orchiectomy without the striking impact of gonadectomy on other enzymes in both sexes. Conclusions: Our results reveal obvious sex differences and roles of sex hormones in LM biosynthetic networks in acute self-resolving inflammation in mice, with several preponderances in males that appear under the control of androgens.

Highlights

  • Sex differences in inflammation are obvious and contribute to divergences in the incidence and severity of inflammation-related diseases that frequently preponderate in women

  • In order to investigate if lipid mediator (LM) signature profiles produced during acute inflammation differ in mammals between sexes, we employed the well-established and suitable model of zymosaninduced peritonitis in male and female mice (Cash et al, 2009; Rossi et al, 2014)

  • Targeted LM metabololipidomics using UPLC–MS-MS of peritoneal exudates were obtained from mice 4 h after zymosan injection, which is the temporal peak of inflammatory reactions (Rossi et al, 2014), and 24 h postzymosan, which corresponds to the onset of inflammation resolution (Serhan, 2014)

Read more

Summary

Introduction

Sex differences in inflammation are obvious and contribute to divergences in the incidence and severity of inflammation-related diseases that frequently preponderate in women. While PGs/TXs and LTs are rapidly produced at the onset of inflammation where they initialize and maintain the inflammatory process, the formation of SPMs is delayed and is crucial for the termination of inflammation and for the return to homeostasis (Serhan and Savill 2005; Serhan 2014; Serhan and Levy 2018). Imbalances of these pro-inflammatory and inflammation-resolving LMs may result in excessive and persistent inflammation where PG/TX and LT dominate and SPM levels are low (Tabas and Glass 2013; Chiang and Serhan 2020). Chronic inflammatory diseases like asthma and arthritis, cardiovascular diseases, Alzheimer’s disease, type 2 diabetes, and cancer are afflicted with increased ratios of proinflammatory eicosanoids vs SPMs (Serhan and Levy 2018; Dalli and Serhan 2019; Chiang and Serhan 2020)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call